Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Renal cell carcinoma (RCC) is a significant malignancy.
• Oncogene expression is crucial in cancer development and progression.
• Understanding specific oncogene alterations in RCC can inform diagnosis and treatment.

Purpose of the Study:

• To analyze the expression of key oncogenes: epidermal growth factor (EGF) receptor, HER2/neu, c-myc, and c-fos.
• To investigate the relationship between oncogene expression and tumor characteristics in RCC.
• To determine if chromosomal abnormalities are associated with these oncogene alterations.

Main Methods:

• Northern blot analysis was used to quantify gene expression in 30 RCC patient samples and matched non-neoplastic kidney tissue.
• Southern blot analysis was performed on six RCC samples to detect chromosomal rearrangements or gene amplification.

Main Results:

• High expression of the EGF receptor gene was observed in 73% of RCC cases (22/30).
• Conversely, low expression of the HER2/neu gene was found in 93% of RCC cases (28/30), indicating an inverse relationship.
• Altered expression patterns of c-myc and c-fos oncogenes were detected and appeared to correlate with tumor grade of malignancy.
• Southern blot analysis did not reveal any evidence of chromosomal rearrangement events or gene amplification in the analyzed RCC samples.

Conclusions:

• The study identified a significant inverse relationship between EGF receptor and HER2/neu expression in renal cell carcinoma.
• Altered expression of c-myc and c-fos oncogenes may serve as potential biomarkers for RCC malignancy grade.
• The findings suggest that genetic alterations like rearrangements or amplifications are not the primary drivers of these specific oncogene expression changes in the studied RCC cohort.